SummitTX Capital »

Dianthus Therapeutics shares owned by SummitTX Capital

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.6M 88k 41.21

More positions owned by SummitTX Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Asml Holding N V N Y Registry Shs (ASML)
Eli Lilly & Co. (LLY)
MKS Instruments (MKSI)
Wal-Mart Stores (WMT)
Paypal Holdings (PYPL)
Applied Materials (AMAT)
Amazon (AMZN)
Anthem (ELV)
Costco Wholesale Corporation (COST)
UnitedHealth (UNH)
Meritage Homes Corporation (MTH)

View all positions for SummitTX Capital

Top funds holding Dianthus Therapeutics

FMR
RA Capital Management
Wellington Management Company
Octagon Capital Advisors
Fairmount Funds Management
Avidity Partners Management
Vanguard Group
BlackRock
TCG Crossover Management
State Street Corporation
Braidwell
Point72 Asset Management
Citadel Advisors
Marshall Wace
Polar Capital Holdings

View all funds holding Dianthus Therapeutics